Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001477932-24-000913
Filing Date
2024-02-27
Accepted
2024-02-27 13:46:55
Documents
1
Period of Report
2023-12-29

Document Format Files

Seq Description Document Type Size
1 FORM 4 form4.html 4  
1 FORM 4 form4.xml 4 3241
  Complete submission text file 0001477932-24-000913.txt   4655
Mailing Address 631 US HWY 1, SUITE 407 NORTH PALM BEACH FL 33408
Business Address 631 US HWY 1, SUITE 407 NORTH PALM BEACH FL 33408 612-961-5656
Nascent Biotech Inc. (Issuer) CIK: 0001622057 (see all company filings)

EIN.: 450612715 | State of Incorp.: NV | Fiscal Year End: 0331
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)

Mailing Address 631 US HWY 1 SUITE 407 NORTH PALM BEACH FL 33408
Business Address
Carrick Sean (Reporting) CIK: 0001629693 (see all company filings)

Type: 4 | Act: 34 | File No.: 000-55299 | Film No.: 24684957